APPLICATION OF AN OBJECTIVE METHOD FOR MEASURING THE ACTION OF "ANTIDEPRESSANT" MEDICATIONS
Abstract
Most investigations of "antidepressant" medications have depended on clinical assessment of the symptom. This study undertook to apply an objective measure of depression to determine the effectiveness of nialamide, as representative of monoamine oxidase inhibitors, in a state hospital population.
The results showed that both ward behaviour and depression improved significantly more in a high dosage group than for the low dosage and control groups but at the risk of additional behavioral and physical side effects. It was concluded that the measure of depression employed has merit and that nialamide used watchfully in high doses represents a worthwhile contribution for the treatment of the depressed or apathetic patient.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
